InvestorsHub Logo
Followers 4
Posts 1242
Boards Moderated 0
Alias Born 01/16/2016

Re: None

Sunday, 01/17/2016 1:16:44 PM

Sunday, January 17, 2016 1:16:44 PM

Post# of 6602
Pure speculation: Nutter McClennan & Fish, who's lawyers advised Ekso Bionics in the most recent direct acquisition also have the following clients: Johnson & Johnson, and Cigna.

It is a possibility that the person/peoples who are buying EKSO stock now are in communication with one of these larger companies which may have plans to acquire Ekso Bionics.

Perhaps they run into each other in the vestibule outside the office. Better yet, Ekso may have started using this firm on the advice of the buying party. It could even be a group deal so that insurance companies agree to 'subsidize' costs for the buying party with the cost to insurance members.

I think the current situation is a squeeze to force small time investors out while preparing for profit. The company will move forward soon, but it might raise eyebrows about insider trading if they advance too quickly right after a 15m buy in.

To be clear, I have no reason or evidence to believe that any of these things are actually occurring. My only source is the name of the law firm and Wiki for they represent.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News